Mindax Limited · ASX:MDX

Mindax — Corporate Update (December 2018)

4 slides from Mindax's corporate update, Dec 12, 2018

  1. Slide 1: Company Update

    PRINCIPAL OFFICE Suite 2, 11 Ventnor Avenue, West Perth WA 6005 PO Box 1153, West Perth WA 6872 T +61 8 9389 2111 www.mindax.com.au ABN 28 106 866 442 For personal use only 12 December 2018 COMPANY UPDATE The Company is pleased to provide this operational update on the Company's activities. The Comp

  2. Slide 2: Letter of intent (Chinese version)

    Rt SRN a Faas Oy, BRUIT MERE RI RA BA HEAUICA. Ea ZT BAA BRA FEAR: AHA FRR: MDX DLA. OMAR YS. GTB. WS. (RAE RR AEM —s CARA RTT ROR A TEAC FORA CHIR, MALIA i NARA; FCMATBMERED. ST EUSRAAE, TAME A A, RAT IER AE, FRU LE IAL OME SCM, BAMA EI, FEA — FL EAE SR AULT els FE A — Fa eB URE MAS, Ey US A TT SH

  3. Slide 3: Australia-China Prosperous Age And Australia's Mindax Limited Cooperation Letter Of Intent

    Australia-China Prosperous Age And Australia’s Mindax Limited Cooperation Letter Of Intent Party A: ShenZhen QianHai Australia-China Prosperous Age Biotechnology Co., Ltd. Authorized Representative: Jackie Lian Party B: Australia Mindax Limited Authorized Representative: Benjamin Chow Stock Code: MD

  4. Slide 4: Letter of intent terms and signature page

    If there is any violation, the relevant laws and regulations of the two countries shall prevail; the unfinished matters shall be implemented in accordance with relevant laws and regulations. If the regulations are not specified, both parties may reach a written supplemental agreement. The attachment

Mindax — Corporate Update (December 2018) on 6ix